Outlook Therapeutics, Inc. (OTLK)
0.4882
-0.01
(-2.36%)
USD |
NASDAQ |
Oct 16, 16:00
0.4918
0.00 (0.00%)
After-Hours: 20:00
Outlook Therapeutics Market Cap : 91.34M for Oct. 16, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 16, 2026 | 91.34M |
| October 15, 2026 | 93.55M |
| October 14, 2026 | 87.97M |
| October 13, 2026 | 105.49M |
| October 12, 2026 | 109.47M |
| October 09, 2026 | 112.05M |
| October 08, 2026 | 105.52M |
| October 07, 2026 | 110.39M |
| October 06, 2026 | 107.02M |
| October 05, 2026 | 111.42M |
| October 02, 2026 | 110.95M |
| October 01, 2026 | 107.58M |
| September 30, 2026 | 107.30M |
| September 29, 2026 | 117.07M |
| September 28, 2026 | 116.21M |
| September 25, 2026 | 119.65M |
| September 24, 2026 | 122.70M |
| September 23, 2026 | 123.80M |
| September 22, 2026 | 130.26M |
| September 21, 2026 | 128.40M |
| September 18, 2026 | 122.10M |
| September 17, 2026 | 127.41M |
| September 16, 2026 | 126.65M |
| September 15, 2026 | 125.92M |
| September 14, 2026 | 119.35M |
| Date | Value |
|---|---|
| September 11, 2026 | 123.48M |
| September 10, 2026 | 123.71M |
| September 09, 2026 | 120.47M |
| September 08, 2026 | 119.84M |
| September 04, 2026 | 124.70M |
| September 03, 2026 | 121.43M |
| September 02, 2026 | 117.18M |
| September 01, 2026 | 116.58M |
| August 31, 2026 | 118.51M |
| August 28, 2026 | 120.66M |
| August 27, 2026 | 119.95M |
| August 26, 2026 | 116.62M |
| August 25, 2026 | 119.74M |
| August 24, 2026 | 113.94M |
| August 21, 2026 | 121.09M |
| August 20, 2026 | 126.53M |
| August 19, 2026 | 129.12M |
| August 18, 2026 | 130.97M |
| August 17, 2026 | 125.77M |
| August 14, 2026 | 141.52M |
| August 13, 2026 | 92.98M |
| August 12, 2026 | 115.08M |
| August 11, 2026 | 118.21M |
| August 10, 2026 | 120.31M |
| August 07, 2026 | 106.71M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Valion Bio, Inc. | 0.1943M |
| Agenus, Inc. | 257.40M |
| Amgen, Inc. | 233.80B |
| Anika Therapeutics, Inc. | 267.39M |
| BioCryst Pharmaceuticals, Inc. | 1.989B |
Market Cap Related Metrics
| PS Ratio | 88.87 |
| Price | 0.4882 |
| Earnings Yield | -231.7% |